Wellington Management Company »

Avalo Therapeutics Ord shares owned by Wellington Management Company

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9M 105k 18.48

More positions owned by Wellington Management Company

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Merck & Co (MRK)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Johnson & Johnson (JNJ)
Advanced Micro Devices (AMD)
Astrazeneca Ord (AZN)
Kla Corp Com New (KLAC)

View all positions for Wellington Management Company

Top funds holding Avalo Therapeutics Ord

FMR
BlackRock
Deep Track Capital
Caligan Partners
TCG Crossover Management
Affinity Asset Advisors
Farallon Capital Management
Point72 Asset Management
venBio Select Advisor
Vanguard Capital Management
BVF
Bank of America Corporation
Nantahala Capital Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Avalo Therapeutics Ord